← Back to Screener
Ginkgo Bioworks Holdings, Inc. (DNA)
Price$8.22
Value ScoreB
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-19.35%
Price vs S&P 500 (4W)-7.94%
VGM Score52.87
Market Capitalization$536.97M
All Metrics
Book Value / Share (Quarterly)$7.19
P/TBV (Annual)1.11x
Revenue Growth (3Y)-29.11%
Cash Flow / Share (Quarterly)$-2.73
Price vs S&P 500 (YTD)-9.24%
Gross Margin (TTM)73.09%
Net Profit Margin (TTM)-215.41%
EPS (TTM)$-5.35
10-Day Avg Trading Volume1.62M
EPS Excl Extra (TTM)$-5.35
Revenue Growth (5Y)17.28%
EPS (Annual)$-5.64
ROI (Annual)-61.49%
Gross Margin (Annual)72.39%
Net Profit Margin (5Y Avg)-360.73%
Cash / Share (Quarterly)$6.06
Revenue Growth QoQ (YoY)-59.70%
ROA (Last FY)-27.93%
Revenue Growth TTM (YoY)-40.48%
EBITD / Share (TTM)$-4.50
ROE (5Y Avg)-92.41%
Operating Margin (TTM)-220.92%
Cash Flow / Share (Annual)$-3.07
P/B Ratio1.21x
P/B Ratio (Quarterly)0.82x
Net Income / Employee (Annual)$-644,900
EV / Revenue (TTM)2.78x
Net Interest Coverage (TTM)-2640.83x
ROA (TTM)-26.63%
EPS Incl Extra (Annual)$-5.64
Current Ratio (Annual)4.92x
Quick Ratio (Quarterly)5.03x
3-Month Avg Trading Volume1.27M
52-Week Price Return13.69%
Revenue / Employee (TTM)$291,400
Tangible BV / Share (Quarterly)$6.39
P/S Ratio (Annual)3.16x
Asset Turnover (Annual)0.15x
52-Week High$17.58
Operating Margin (5Y Avg)-370.56%
EPS Excl Extra (Annual)$-5.64
CapEx CAGR (5Y)-33.24%
26-Week Price Return-11.42%
Quick Ratio (Annual)4.73x
13-Week Price Return20.18%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.15x
Enterprise Value$393.10M
Revenue / Share Growth (5Y)137.15%
Asset Turnover (TTM)0.12x
Revenue / Employee (Annual)$350,800
Inventory Turnover (Annual)24.29x
Pretax Margin (Annual)-184.30%
Cash / Share (Annual)$7.26
3-Month Return Std Dev94.32%
Gross Margin (5Y Avg)69.44%
Net Income / Employee (TTM)$-627,600
ROE (Last FY)-61.50%
Net Interest Coverage (Annual)-16.40x
EPS Basic Excl Extra (Annual)$-5.64
Receivables Turnover (TTM)5.96x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.35
Receivables Turnover (Annual)7.29x
ROI (TTM)-57.31%
P/S Ratio (TTM)3.80x
Pretax Margin (5Y Avg)-362.08%
Revenue / Share (Annual)$3.07
Tangible BV / Share (Annual)$7.76
Price vs S&P 500 (52W)-10.67%
Year-to-Date Return-1.08%
5-Day Price Return-10.07%
EPS Normalized (Annual)$-5.64
ROA (5Y Avg)-58.50%
Net Profit Margin (Annual)-183.81%
Month-to-Date Return-12.27%
Cash Flow / Share (TTM)$-0.41
EBITD / Share (Annual)$-4.92
Operating Margin (Annual)-194.89%
ROI (5Y Avg)-92.03%
EPS Basic Excl Extra (TTM)$-5.35
P/TBV (Quarterly)0.92x
P/B Ratio (Annual)0.99x
Inventory Turnover (TTM)24.30x
Pretax Margin (TTM)-211.50%
Book Value / Share (Annual)$8.74
Price vs S&P 500 (13W)11.92%
Beta1.78x
Revenue / Share (TTM)$2.37
ROE (TTM)-57.31%
52-Week Low$5.37
vGradeB
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-1.39est. -1.09
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.09
2.09
2.09
2.09
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DNAGinkgo Bioworks Holdings, Inc. | B | D | C | $8.22 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Ginkgo Bioworks provides a cell programming platform offering biological R&D services and end-to-end solutions across pharmaceuticals, agriculture, food, and industrial markets. The company operates two segments: Cell Engineering, which generates the majority of revenue through customer biological research and development, and Biosecurity, which provides biological threat identification, monitoring, and mitigation services for government and commercial customers.